Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
TEVA

Teva

$18.38

1.08 (6.24%)

13:10
12/15/17
12/15
13:10
12/15/17
13:10
Options
Teva calls active as shares rally further »

Teva calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.40

1.1 (6.36%)

12:57
12/15/17
12/15
12:57
12/15/17
12:57
Recommendations
Teva analyst commentary at Deutsche Bank »

Teva price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.42

1.116 (6.45%)

10:44
12/15/17
12/15
10:44
12/15/17
10:44
Upgrade
Teva rating change at Credit Suisse »

Credit Suisse takes Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.39

1.08 (6.24%)

10:37
12/15/17
12/15
10:37
12/15/17
10:37
Upgrade
Teva rating change at Morgan Stanley »

Teva upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.21

0.91 (5.26%)

10:24
12/15/17
12/15
10:24
12/15/17
10:24
Upgrade
Teva rating change at Morgan Stanley »

Teva upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

09:40
12/15/17
12/15
09:40
12/15/17
09:40
Upgrade
Teva rating change at Credit Suisse »

Teva upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.30

1.6 (10.19%)

09:03
12/15/17
12/15
09:03
12/15/17
09:03
Hot Stocks
Teva announces exclusive launch of generic Viread tablets in the U.S. »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

08:07
12/15/17
12/15
08:07
12/15/17
08:07
Recommendations
Teva analyst commentary at BTIG »

Teva price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.30

1.6 (10.19%)

08:01
12/15/17
12/15
08:01
12/15/17
08:01
Technical Analysis
Technical View: Teva moves higher in pre-market, analyst action »

At time of writing in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.30

1.6 (10.19%)

, TWTR

Twitter

$22.58

0.92 (4.25%)

07:35
12/15/17
12/15
07:35
12/15/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

TEVA

Teva

$17.30

1.6 (10.19%)

TWTR

Twitter

$22.58

0.92 (4.25%)

TWX

Time Warner

$89.65

-0.41 (-0.46%)

ORCL

Oracle

$50.19

0.14 (0.28%)

LOW

Lowe's

$85.58

-0.02 (-0.02%)

BX

Blackstone

$31.72

-0.27 (-0.84%)

AGN

Allergan

$170.94

1.7 (1.00%)

MYL

Mylan

$40.01

0.48 (1.21%)

ETP

Energy Transfer Partners

$17.42

0.15 (0.87%)

MAC

Macerich

$66.57

-0.2 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 07

    Feb

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.